nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—ALB—Estropipate—osteoporosis	0.166	0.318	CbGbCtD
Clonazepam—ALB—Estradiol—osteoporosis	0.0688	0.132	CbGbCtD
Clonazepam—CYP3A4—Estropipate—osteoporosis	0.0519	0.0997	CbGbCtD
Clonazepam—CYP3A4—Calcitriol—osteoporosis	0.0519	0.0997	CbGbCtD
Clonazepam—CYP3A4—Ergocalciferol—osteoporosis	0.0415	0.0797	CbGbCtD
Clonazepam—CYP3A4—Raloxifene—osteoporosis	0.0346	0.0665	CbGbCtD
Clonazepam—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0334	0.0642	CbGbCtD
Clonazepam—CYP3A4—Cholecalciferol—osteoporosis	0.0267	0.0514	CbGbCtD
Clonazepam—CYP3A4—Conjugated Estrogens—osteoporosis	0.0245	0.0472	CbGbCtD
Clonazepam—CYP3A4—Estradiol—osteoporosis	0.0215	0.0414	CbGbCtD
Clonazepam—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000797	0.0449	CbGpPWpGaD
Clonazepam—Chlorthalidone—CA2—osteoporosis	0.000761	1	CrCbGaD
Clonazepam—NAT2—Biological oxidations—CYP27A1—osteoporosis	0.000443	0.0249	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000437	0.0246	CbGpPWpGaD
Clonazepam—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—osteoporosis	0.000393	0.0221	CbGpPWpGaD
Clonazepam—GABRB2—Orphan transporters—ANXA2—osteoporosis	0.000302	0.017	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—WDR1—osteoporosis	0.000297	0.0167	CbGpPWpGaD
Clonazepam—GABRA3—Orphan transporters—ANXA2—osteoporosis	0.000288	0.0162	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.000283	0.0159	CbGpPWpGaD
Clonazepam—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000282	0.0159	CbGpPWpGaD
Clonazepam—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000277	0.0156	CbGpPWpGaD
Clonazepam—GABRG2—Orphan transporters—ANXA2—osteoporosis	0.000276	0.0155	CbGpPWpGaD
Clonazepam—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000271	0.0153	CbGpPWpGaD
Clonazepam—Anorexia—Pamidronate—osteoporosis	0.000271	0.000588	CcSEcCtD
Clonazepam—Chest pain—Zoledronate—osteoporosis	0.000271	0.000588	CcSEcCtD
Clonazepam—Myalgia—Zoledronate—osteoporosis	0.000271	0.000588	CcSEcCtD
Clonazepam—Arthralgia—Zoledronate—osteoporosis	0.000271	0.000588	CcSEcCtD
Clonazepam—Palpitations—Conjugated Estrogens—osteoporosis	0.000271	0.000588	CcSEcCtD
Clonazepam—Insomnia—Risedronate—osteoporosis	0.000271	0.000587	CcSEcCtD
Clonazepam—Anxiety—Zoledronate—osteoporosis	0.00027	0.000586	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000269	0.000584	CcSEcCtD
Clonazepam—Pruritus—Estropipate—osteoporosis	0.000268	0.000581	CcSEcCtD
Clonazepam—Discomfort—Zoledronate—osteoporosis	0.000268	0.000581	CcSEcCtD
Clonazepam—Asthenia—Alendronate—osteoporosis	0.000268	0.00058	CcSEcCtD
Clonazepam—Hypersensitivity—Ibandronate—osteoporosis	0.000267	0.00058	CcSEcCtD
Clonazepam—Cough—Conjugated Estrogens—osteoporosis	0.000267	0.00058	CcSEcCtD
Clonazepam—Dyspnoea—Risedronate—osteoporosis	0.000267	0.000579	CcSEcCtD
Clonazepam—Hypotension—Pamidronate—osteoporosis	0.000266	0.000577	CcSEcCtD
Clonazepam—Dry mouth—Zoledronate—osteoporosis	0.000265	0.000575	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000265	0.000575	CcSEcCtD
Clonazepam—Fatigue—Ethinyl Estradiol—osteoporosis	0.000265	0.000574	CcSEcCtD
Clonazepam—Pruritus—Alendronate—osteoporosis	0.000264	0.000572	CcSEcCtD
Clonazepam—Dyspepsia—Risedronate—osteoporosis	0.000263	0.000571	CcSEcCtD
Clonazepam—Eye disorder—Estradiol—osteoporosis	0.000263	0.000571	CcSEcCtD
Clonazepam—Constipation—Ethinyl Estradiol—osteoporosis	0.000262	0.000569	CcSEcCtD
Clonazepam—Confusional state—Zoledronate—osteoporosis	0.000262	0.000568	CcSEcCtD
Clonazepam—Hypersensitivity—Calcitriol—osteoporosis	0.000262	0.000568	CcSEcCtD
Clonazepam—Cardiac disorder—Estradiol—osteoporosis	0.000262	0.000567	CcSEcCtD
Clonazepam—Flushing—Estradiol—osteoporosis	0.000262	0.000567	CcSEcCtD
Clonazepam—Arthralgia—Conjugated Estrogens—osteoporosis	0.000261	0.000566	CcSEcCtD
Clonazepam—Chest pain—Conjugated Estrogens—osteoporosis	0.000261	0.000566	CcSEcCtD
Clonazepam—Myalgia—Conjugated Estrogens—osteoporosis	0.000261	0.000566	CcSEcCtD
Clonazepam—Asthenia—Ibandronate—osteoporosis	0.00026	0.000565	CcSEcCtD
Clonazepam—Anxiety—Conjugated Estrogens—osteoporosis	0.00026	0.000564	CcSEcCtD
Clonazepam—Nausea—Etidronic acid—osteoporosis	0.00026	0.000564	CcSEcCtD
Clonazepam—Anaphylactic shock—Zoledronate—osteoporosis	0.00026	0.000564	CcSEcCtD
Clonazepam—Oedema—Zoledronate—osteoporosis	0.00026	0.000564	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000259	0.000562	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000259	0.000562	CcSEcCtD
Clonazepam—Diarrhoea—Estropipate—osteoporosis	0.000259	0.000562	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Risedronate—osteoporosis	0.000258	0.00056	CcSEcCtD
Clonazepam—Infection—Zoledronate—osteoporosis	0.000258	0.00056	CcSEcCtD
Clonazepam—Fatigue—Risedronate—osteoporosis	0.000258	0.00056	CcSEcCtD
Clonazepam—Insomnia—Pamidronate—osteoporosis	0.000257	0.000558	CcSEcCtD
Clonazepam—Pruritus—Ibandronate—osteoporosis	0.000257	0.000557	CcSEcCtD
Clonazepam—Constipation—Risedronate—osteoporosis	0.000256	0.000555	CcSEcCtD
Clonazepam—Pain—Risedronate—osteoporosis	0.000256	0.000555	CcSEcCtD
Clonazepam—Diarrhoea—Alendronate—osteoporosis	0.000255	0.000554	CcSEcCtD
Clonazepam—Asthenia—Calcitriol—osteoporosis	0.000255	0.000553	CcSEcCtD
Clonazepam—Nervous system disorder—Zoledronate—osteoporosis	0.000255	0.000553	CcSEcCtD
Clonazepam—Immune system disorder—Estradiol—osteoporosis	0.000255	0.000552	CcSEcCtD
Clonazepam—Thrombocytopenia—Zoledronate—osteoporosis	0.000254	0.000552	CcSEcCtD
Clonazepam—Dyspnoea—Pamidronate—osteoporosis	0.000254	0.00055	CcSEcCtD
Clonazepam—Tachycardia—Zoledronate—osteoporosis	0.000254	0.00055	CcSEcCtD
Clonazepam—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000253	0.000549	CcSEcCtD
Clonazepam—Chills—Estradiol—osteoporosis	0.000253	0.000549	CcSEcCtD
Clonazepam—Somnolence—Pamidronate—osteoporosis	0.000253	0.000549	CcSEcCtD
Clonazepam—Skin disorder—Zoledronate—osteoporosis	0.000252	0.000547	CcSEcCtD
Clonazepam—Pruritus—Calcitriol—osteoporosis	0.000251	0.000545	CcSEcCtD
Clonazepam—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000251	0.000544	CcSEcCtD
Clonazepam—Diarrhoea—Raloxifene—osteoporosis	0.000251	0.000544	CcSEcCtD
Clonazepam—Dyspepsia—Pamidronate—osteoporosis	0.00025	0.000543	CcSEcCtD
Clonazepam—Dizziness—Estropipate—osteoporosis	0.00025	0.000543	CcSEcCtD
Clonazepam—Oedema—Conjugated Estrogens—osteoporosis	0.00025	0.000543	CcSEcCtD
Clonazepam—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00025	0.000543	CcSEcCtD
Clonazepam—Alopecia—Estradiol—osteoporosis	0.000249	0.00054	CcSEcCtD
Clonazepam—Infection—Conjugated Estrogens—osteoporosis	0.000249	0.000539	CcSEcCtD
Clonazepam—Diarrhoea—Ibandronate—osteoporosis	0.000248	0.000539	CcSEcCtD
Clonazepam—Anorexia—Zoledronate—osteoporosis	0.000248	0.000537	CcSEcCtD
Clonazepam—Decreased appetite—Pamidronate—osteoporosis	0.000247	0.000536	CcSEcCtD
Clonazepam—Mental disorder—Estradiol—osteoporosis	0.000247	0.000536	CcSEcCtD
Clonazepam—Dizziness—Alendronate—osteoporosis	0.000247	0.000535	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000246	0.000533	CcSEcCtD
Clonazepam—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000245	0.000532	CcSEcCtD
Clonazepam—Malnutrition—Estradiol—osteoporosis	0.000245	0.000532	CcSEcCtD
Clonazepam—Fatigue—Pamidronate—osteoporosis	0.000245	0.000532	CcSEcCtD
Clonazepam—Gastrointestinal pain—Risedronate—osteoporosis	0.000245	0.000531	CcSEcCtD
Clonazepam—Tachycardia—Conjugated Estrogens—osteoporosis	0.000244	0.00053	CcSEcCtD
Clonazepam—Urticaria—Ethinyl Estradiol—osteoporosis	0.000244	0.000529	CcSEcCtD
Clonazepam—Constipation—Pamidronate—osteoporosis	0.000243	0.000528	CcSEcCtD
Clonazepam—Pain—Pamidronate—osteoporosis	0.000243	0.000528	CcSEcCtD
Clonazepam—Diarrhoea—Calcitriol—osteoporosis	0.000243	0.000528	CcSEcCtD
Clonazepam—Skin disorder—Conjugated Estrogens—osteoporosis	0.000243	0.000527	CcSEcCtD
Clonazepam—Hypotension—Zoledronate—osteoporosis	0.000243	0.000527	CcSEcCtD
Clonazepam—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000243	0.000526	CcSEcCtD
Clonazepam—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000243	0.000526	CcSEcCtD
Clonazepam—Dizziness—Raloxifene—osteoporosis	0.000243	0.000526	CcSEcCtD
Clonazepam—Flatulence—Estradiol—osteoporosis	0.000242	0.000524	CcSEcCtD
Clonazepam—GABRA1—Orphan transporters—ANXA2—osteoporosis	0.000241	0.0136	CbGpPWpGaD
Clonazepam—Tension—Estradiol—osteoporosis	0.000241	0.000522	CcSEcCtD
Clonazepam—Vomiting—Estropipate—osteoporosis	0.000241	0.000522	CcSEcCtD
Clonazepam—Dizziness—Ibandronate—osteoporosis	0.00024	0.000521	CcSEcCtD
Clonazepam—Rash—Estropipate—osteoporosis	0.000239	0.000518	CcSEcCtD
Clonazepam—Dermatitis—Estropipate—osteoporosis	0.000238	0.000517	CcSEcCtD
Clonazepam—Anorexia—Conjugated Estrogens—osteoporosis	0.000238	0.000517	CcSEcCtD
Clonazepam—Nervousness—Estradiol—osteoporosis	0.000238	0.000517	CcSEcCtD
Clonazepam—Urticaria—Risedronate—osteoporosis	0.000238	0.000516	CcSEcCtD
Clonazepam—Back pain—Estradiol—osteoporosis	0.000237	0.000515	CcSEcCtD
Clonazepam—Headache—Estropipate—osteoporosis	0.000237	0.000515	CcSEcCtD
Clonazepam—Vomiting—Alendronate—osteoporosis	0.000237	0.000514	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000237	0.000514	CcSEcCtD
Clonazepam—Body temperature increased—Risedronate—osteoporosis	0.000237	0.000513	CcSEcCtD
Clonazepam—Abdominal pain—Risedronate—osteoporosis	0.000237	0.000513	CcSEcCtD
Clonazepam—Muscle spasms—Estradiol—osteoporosis	0.000236	0.000512	CcSEcCtD
Clonazepam—Rash—Alendronate—osteoporosis	0.000235	0.00051	CcSEcCtD
Clonazepam—Insomnia—Zoledronate—osteoporosis	0.000235	0.00051	CcSEcCtD
Clonazepam—Dermatitis—Alendronate—osteoporosis	0.000235	0.00051	CcSEcCtD
Clonazepam—ALB—Platelet degranulation—CAP1—osteoporosis	0.000234	0.0132	CbGpPWpGaD
Clonazepam—Feeling abnormal—Pamidronate—osteoporosis	0.000234	0.000508	CcSEcCtD
Clonazepam—Hypotension—Conjugated Estrogens—osteoporosis	0.000234	0.000507	CcSEcCtD
Clonazepam—Headache—Alendronate—osteoporosis	0.000234	0.000507	CcSEcCtD
Clonazepam—Vomiting—Raloxifene—osteoporosis	0.000233	0.000506	CcSEcCtD
Clonazepam—NAT2—Biological oxidations—CYP19A1—osteoporosis	0.000233	0.0131	CbGpPWpGaD
Clonazepam—Gastrointestinal pain—Pamidronate—osteoporosis	0.000233	0.000505	CcSEcCtD
Clonazepam—Dyspnoea—Zoledronate—osteoporosis	0.000232	0.000502	CcSEcCtD
Clonazepam—Rash—Raloxifene—osteoporosis	0.000231	0.000502	CcSEcCtD
Clonazepam—Dermatitis—Raloxifene—osteoporosis	0.000231	0.000501	CcSEcCtD
Clonazepam—Somnolence—Zoledronate—osteoporosis	0.000231	0.000501	CcSEcCtD
Clonazepam—Vomiting—Ibandronate—osteoporosis	0.000231	0.000501	CcSEcCtD
Clonazepam—Tremor—Estradiol—osteoporosis	0.00023	0.000499	CcSEcCtD
Clonazepam—Headache—Raloxifene—osteoporosis	0.00023	0.000498	CcSEcCtD
Clonazepam—NAT2—Metapathway biotransformation—CYP19A1—osteoporosis	0.00023	0.0129	CbGpPWpGaD
Clonazepam—Rash—Ibandronate—osteoporosis	0.000229	0.000497	CcSEcCtD
Clonazepam—Dermatitis—Ibandronate—osteoporosis	0.000229	0.000496	CcSEcCtD
Clonazepam—Dyspepsia—Zoledronate—osteoporosis	0.000229	0.000496	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000228	0.000494	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000228	0.0128	CbGpPWpGaD
Clonazepam—Ill-defined disorder—Estradiol—osteoporosis	0.000228	0.000494	CcSEcCtD
Clonazepam—Headache—Ibandronate—osteoporosis	0.000227	0.000493	CcSEcCtD
Clonazepam—Insomnia—Conjugated Estrogens—osteoporosis	0.000226	0.000491	CcSEcCtD
Clonazepam—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000226	0.00049	CcSEcCtD
Clonazepam—Vomiting—Calcitriol—osteoporosis	0.000226	0.00049	CcSEcCtD
Clonazepam—Decreased appetite—Zoledronate—osteoporosis	0.000226	0.00049	CcSEcCtD
Clonazepam—Agitation—Estradiol—osteoporosis	0.000225	0.000489	CcSEcCtD
Clonazepam—Nausea—Estropipate—osteoporosis	0.000225	0.000488	CcSEcCtD
Clonazepam—Abdominal pain—Pamidronate—osteoporosis	0.000225	0.000488	CcSEcCtD
Clonazepam—Body temperature increased—Pamidronate—osteoporosis	0.000225	0.000488	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000224	0.000487	CcSEcCtD
Clonazepam—Angioedema—Estradiol—osteoporosis	0.000224	0.000486	CcSEcCtD
Clonazepam—Rash—Calcitriol—osteoporosis	0.000224	0.000486	CcSEcCtD
Clonazepam—Fatigue—Zoledronate—osteoporosis	0.000224	0.000486	CcSEcCtD
Clonazepam—Dermatitis—Calcitriol—osteoporosis	0.000224	0.000486	CcSEcCtD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000223	0.0126	CbGpPWpGaD
Clonazepam—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000223	0.000484	CcSEcCtD
Clonazepam—Headache—Calcitriol—osteoporosis	0.000223	0.000483	CcSEcCtD
Clonazepam—Somnolence—Conjugated Estrogens—osteoporosis	0.000222	0.000482	CcSEcCtD
Clonazepam—Pain—Zoledronate—osteoporosis	0.000222	0.000482	CcSEcCtD
Clonazepam—Constipation—Zoledronate—osteoporosis	0.000222	0.000482	CcSEcCtD
Clonazepam—Nausea—Alendronate—osteoporosis	0.000221	0.000481	CcSEcCtD
Clonazepam—Malaise—Estradiol—osteoporosis	0.000221	0.00048	CcSEcCtD
Clonazepam—Hypersensitivity—Risedronate—osteoporosis	0.00022	0.000478	CcSEcCtD
Clonazepam—Vertigo—Estradiol—osteoporosis	0.00022	0.000478	CcSEcCtD
Clonazepam—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00022	0.000478	CcSEcCtD
Clonazepam—Asthenia—Ethinyl Estradiol—osteoporosis	0.00022	0.000478	CcSEcCtD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000218	0.0123	CbGpPWpGaD
Clonazepam—Nausea—Raloxifene—osteoporosis	0.000218	0.000473	CcSEcCtD
Clonazepam—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000217	0.000472	CcSEcCtD
Clonazepam—Pruritus—Ethinyl Estradiol—osteoporosis	0.000217	0.000471	CcSEcCtD
Clonazepam—Palpitations—Estradiol—osteoporosis	0.000217	0.00047	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000216	0.000469	CcSEcCtD
Clonazepam—Fatigue—Conjugated Estrogens—osteoporosis	0.000216	0.000468	CcSEcCtD
Clonazepam—Nausea—Ibandronate—osteoporosis	0.000216	0.000468	CcSEcCtD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000215	0.0121	CbGpPWpGaD
Clonazepam—Asthenia—Risedronate—osteoporosis	0.000215	0.000466	CcSEcCtD
Clonazepam—Feeling abnormal—Zoledronate—osteoporosis	0.000214	0.000464	CcSEcCtD
Clonazepam—Cough—Estradiol—osteoporosis	0.000214	0.000464	CcSEcCtD
Clonazepam—Pain—Conjugated Estrogens—osteoporosis	0.000214	0.000464	CcSEcCtD
Clonazepam—Constipation—Conjugated Estrogens—osteoporosis	0.000214	0.000464	CcSEcCtD
Clonazepam—Gastrointestinal pain—Zoledronate—osteoporosis	0.000212	0.000461	CcSEcCtD
Clonazepam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000212	0.0119	CbGpPWpGaD
Clonazepam—Pruritus—Risedronate—osteoporosis	0.000212	0.000459	CcSEcCtD
Clonazepam—Nausea—Calcitriol—osteoporosis	0.000211	0.000458	CcSEcCtD
Clonazepam—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00021	0.000456	CcSEcCtD
Clonazepam—Hypersensitivity—Pamidronate—osteoporosis	0.00021	0.000455	CcSEcCtD
Clonazepam—Myalgia—Estradiol—osteoporosis	0.000209	0.000453	CcSEcCtD
Clonazepam—Chest pain—Estradiol—osteoporosis	0.000209	0.000453	CcSEcCtD
Clonazepam—Arthralgia—Estradiol—osteoporosis	0.000209	0.000453	CcSEcCtD
Clonazepam—Anxiety—Estradiol—osteoporosis	0.000208	0.000452	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000207	0.00045	CcSEcCtD
Clonazepam—Urticaria—Zoledronate—osteoporosis	0.000206	0.000448	CcSEcCtD
Clonazepam—Discomfort—Estradiol—osteoporosis	0.000206	0.000448	CcSEcCtD
Clonazepam—Abdominal pain—Zoledronate—osteoporosis	0.000205	0.000446	CcSEcCtD
Clonazepam—Body temperature increased—Zoledronate—osteoporosis	0.000205	0.000446	CcSEcCtD
Clonazepam—Diarrhoea—Risedronate—osteoporosis	0.000205	0.000444	CcSEcCtD
Clonazepam—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000205	0.000444	CcSEcCtD
Clonazepam—Dry mouth—Estradiol—osteoporosis	0.000204	0.000443	CcSEcCtD
Clonazepam—Asthenia—Pamidronate—osteoporosis	0.000204	0.000443	CcSEcCtD
Clonazepam—Dizziness—Ethinyl Estradiol—osteoporosis	0.000203	0.00044	CcSEcCtD
Clonazepam—Confusional state—Estradiol—osteoporosis	0.000202	0.000438	CcSEcCtD
Clonazepam—Pruritus—Pamidronate—osteoporosis	0.000201	0.000437	CcSEcCtD
Clonazepam—Oedema—Estradiol—osteoporosis	0.0002	0.000434	CcSEcCtD
Clonazepam—Anaphylactic shock—Estradiol—osteoporosis	0.0002	0.000434	CcSEcCtD
Clonazepam—Infection—Estradiol—osteoporosis	0.000199	0.000432	CcSEcCtD
Clonazepam—Urticaria—Conjugated Estrogens—osteoporosis	0.000199	0.000431	CcSEcCtD
Clonazepam—Dizziness—Risedronate—osteoporosis	0.000198	0.000429	CcSEcCtD
Clonazepam—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000198	0.000429	CcSEcCtD
Clonazepam—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000198	0.000429	CcSEcCtD
Clonazepam—Nervous system disorder—Estradiol—osteoporosis	0.000196	0.000426	CcSEcCtD
Clonazepam—Tachycardia—Estradiol—osteoporosis	0.000195	0.000424	CcSEcCtD
Clonazepam—Vomiting—Ethinyl Estradiol—osteoporosis	0.000195	0.000423	CcSEcCtD
Clonazepam—Diarrhoea—Pamidronate—osteoporosis	0.000195	0.000422	CcSEcCtD
Clonazepam—Skin disorder—Estradiol—osteoporosis	0.000194	0.000422	CcSEcCtD
Clonazepam—GABRB2—GABA receptor activation—ADCY5—osteoporosis	0.000194	0.0109	CbGpPWpGaD
Clonazepam—Rash—Ethinyl Estradiol—osteoporosis	0.000193	0.00042	CcSEcCtD
Clonazepam—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000193	0.000419	CcSEcCtD
Clonazepam—Headache—Ethinyl Estradiol—osteoporosis	0.000192	0.000417	CcSEcCtD
Clonazepam—Hypersensitivity—Zoledronate—osteoporosis	0.000191	0.000415	CcSEcCtD
Clonazepam—Vomiting—Risedronate—osteoporosis	0.00019	0.000413	CcSEcCtD
Clonazepam—Rash—Risedronate—osteoporosis	0.000189	0.000409	CcSEcCtD
Clonazepam—Dermatitis—Risedronate—osteoporosis	0.000188	0.000409	CcSEcCtD
Clonazepam—Dizziness—Pamidronate—osteoporosis	0.000188	0.000408	CcSEcCtD
Clonazepam—Headache—Risedronate—osteoporosis	0.000187	0.000407	CcSEcCtD
Clonazepam—Asthenia—Zoledronate—osteoporosis	0.000186	0.000404	CcSEcCtD
Clonazepam—GABRA3—GABA receptor activation—ADCY5—osteoporosis	0.000185	0.0104	CbGpPWpGaD
Clonazepam—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000184	0.0104	CbGpPWpGaD
Clonazepam—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000184	0.0004	CcSEcCtD
Clonazepam—Pruritus—Zoledronate—osteoporosis	0.000184	0.000399	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000182	0.000396	CcSEcCtD
Clonazepam—Nausea—Ethinyl Estradiol—osteoporosis	0.000182	0.000395	CcSEcCtD
Clonazepam—Insomnia—Estradiol—osteoporosis	0.000181	0.000393	CcSEcCtD
Clonazepam—Vomiting—Pamidronate—osteoporosis	0.000181	0.000392	CcSEcCtD
Clonazepam—Asthenia—Conjugated Estrogens—osteoporosis	0.000179	0.000389	CcSEcCtD
Clonazepam—Rash—Pamidronate—osteoporosis	0.000179	0.000389	CcSEcCtD
Clonazepam—Dermatitis—Pamidronate—osteoporosis	0.000179	0.000389	CcSEcCtD
Clonazepam—Dyspnoea—Estradiol—osteoporosis	0.000178	0.000387	CcSEcCtD
Clonazepam—Headache—Pamidronate—osteoporosis	0.000178	0.000387	CcSEcCtD
Clonazepam—Somnolence—Estradiol—osteoporosis	0.000178	0.000386	CcSEcCtD
Clonazepam—Diarrhoea—Zoledronate—osteoporosis	0.000178	0.000386	CcSEcCtD
Clonazepam—Nausea—Risedronate—osteoporosis	0.000178	0.000386	CcSEcCtD
Clonazepam—GABRG2—GABA receptor activation—ADCY5—osteoporosis	0.000178	0.01	CbGpPWpGaD
Clonazepam—Pruritus—Conjugated Estrogens—osteoporosis	0.000177	0.000384	CcSEcCtD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000177	0.00995	CbGpPWpGaD
Clonazepam—Dyspepsia—Estradiol—osteoporosis	0.000176	0.000382	CcSEcCtD
Clonazepam—Decreased appetite—Estradiol—osteoporosis	0.000174	0.000378	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Estradiol—osteoporosis	0.000173	0.000375	CcSEcCtD
Clonazepam—Fatigue—Estradiol—osteoporosis	0.000173	0.000374	CcSEcCtD
Clonazepam—Dizziness—Zoledronate—osteoporosis	0.000172	0.000373	CcSEcCtD
Clonazepam—Constipation—Estradiol—osteoporosis	0.000171	0.000371	CcSEcCtD
Clonazepam—Pain—Estradiol—osteoporosis	0.000171	0.000371	CcSEcCtD
Clonazepam—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000171	0.000371	CcSEcCtD
Clonazepam—ALB—Platelet degranulation—PLEK—osteoporosis	0.00017	0.00959	CbGpPWpGaD
Clonazepam—Nausea—Pamidronate—osteoporosis	0.000169	0.000367	CcSEcCtD
Clonazepam—Dizziness—Conjugated Estrogens—osteoporosis	0.000165	0.000359	CcSEcCtD
Clonazepam—Vomiting—Zoledronate—osteoporosis	0.000165	0.000358	CcSEcCtD
Clonazepam—Feeling abnormal—Estradiol—osteoporosis	0.000165	0.000358	CcSEcCtD
Clonazepam—Rash—Zoledronate—osteoporosis	0.000164	0.000355	CcSEcCtD
Clonazepam—Gastrointestinal pain—Estradiol—osteoporosis	0.000164	0.000355	CcSEcCtD
Clonazepam—Dermatitis—Zoledronate—osteoporosis	0.000164	0.000355	CcSEcCtD
Clonazepam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000163	0.00918	CbGpPWpGaD
Clonazepam—Headache—Zoledronate—osteoporosis	0.000163	0.000353	CcSEcCtD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000162	0.00914	CbGpPWpGaD
Clonazepam—Vomiting—Conjugated Estrogens—osteoporosis	0.000159	0.000345	CcSEcCtD
Clonazepam—Urticaria—Estradiol—osteoporosis	0.000159	0.000345	CcSEcCtD
Clonazepam—Abdominal pain—Estradiol—osteoporosis	0.000158	0.000343	CcSEcCtD
Clonazepam—Body temperature increased—Estradiol—osteoporosis	0.000158	0.000343	CcSEcCtD
Clonazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000158	0.00888	CbGpPWpGaD
Clonazepam—Rash—Conjugated Estrogens—osteoporosis	0.000158	0.000342	CcSEcCtD
Clonazepam—Dermatitis—Conjugated Estrogens—osteoporosis	0.000158	0.000342	CcSEcCtD
Clonazepam—Headache—Conjugated Estrogens—osteoporosis	0.000157	0.00034	CcSEcCtD
Clonazepam—GABRA1—GABA receptor activation—ADCY5—osteoporosis	0.000155	0.00874	CbGpPWpGaD
Clonazepam—Nausea—Zoledronate—osteoporosis	0.000154	0.000335	CcSEcCtD
Clonazepam—Nausea—Conjugated Estrogens—osteoporosis	0.000149	0.000322	CcSEcCtD
Clonazepam—Hypersensitivity—Estradiol—osteoporosis	0.000148	0.00032	CcSEcCtD
Clonazepam—ALB—Platelet degranulation—TLN1—osteoporosis	0.000147	0.00827	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—VCL—osteoporosis	0.000145	0.00816	CbGpPWpGaD
Clonazepam—Asthenia—Estradiol—osteoporosis	0.000144	0.000312	CcSEcCtD
Clonazepam—CYP2E1—Tryptophan metabolism—CYP19A1—osteoporosis	0.000142	0.00798	CbGpPWpGaD
Clonazepam—Pruritus—Estradiol—osteoporosis	0.000142	0.000307	CcSEcCtD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.00014	0.00788	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—POMC—osteoporosis	0.00014	0.00787	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000138	0.00777	CbGpPWpGaD
Clonazepam—Diarrhoea—Estradiol—osteoporosis	0.000137	0.000297	CcSEcCtD
Clonazepam—Dizziness—Estradiol—osteoporosis	0.000132	0.000287	CcSEcCtD
Clonazepam—NAT2—Metabolism—FDPS—osteoporosis	0.000132	0.00743	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PKM—osteoporosis	0.000132	0.00743	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000132	0.00741	CbGpPWpGaD
Clonazepam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000127	0.00717	CbGpPWpGaD
Clonazepam—Vomiting—Estradiol—osteoporosis	0.000127	0.000276	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000127	0.00716	CbGpPWpGaD
Clonazepam—Rash—Estradiol—osteoporosis	0.000126	0.000274	CcSEcCtD
Clonazepam—Dermatitis—Estradiol—osteoporosis	0.000126	0.000274	CcSEcCtD
Clonazepam—Headache—Estradiol—osteoporosis	0.000125	0.000272	CcSEcCtD
Clonazepam—NAT2—Metabolism—GPD2—osteoporosis	0.000125	0.00704	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PGLS—osteoporosis	0.000125	0.00704	CbGpPWpGaD
Clonazepam—Nausea—Estradiol—osteoporosis	0.000119	0.000258	CcSEcCtD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000115	0.00645	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PNP—osteoporosis	0.000114	0.00644	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ATIC—osteoporosis	0.000114	0.00644	CbGpPWpGaD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000113	0.00637	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—FGA—osteoporosis	0.00011	0.00618	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000105	0.00589	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000104	0.00586	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000101	0.0057	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—FGB—osteoporosis	9.99e-05	0.00562	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	9.99e-05	0.00562	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—OXCT1—osteoporosis	9.72e-05	0.00548	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CA2—osteoporosis	9.72e-05	0.00548	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	9.57e-05	0.00539	CbGpPWpGaD
Clonazepam—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	9.53e-05	0.00537	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	9.51e-05	0.00536	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—MGLL—osteoporosis	9.48e-05	0.00534	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP27A1—osteoporosis	9.39e-05	0.00529	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.29e-05	0.00523	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP27A1—osteoporosis	9.26e-05	0.00521	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	8.93e-05	0.00503	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—osteoporosis	8.82e-05	0.00497	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	8.51e-05	0.00479	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	8.43e-05	0.00474	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	8.26e-05	0.00465	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.2e-05	0.00462	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	8.16e-05	0.0046	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—IDH2—osteoporosis	8.06e-05	0.00454	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—SOD2—osteoporosis	7.79e-05	0.00438	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP27A1—osteoporosis	7.58e-05	0.00427	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	7.56e-05	0.00425	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—GPX1—osteoporosis	7.43e-05	0.00418	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ACP5—osteoporosis	7.37e-05	0.00415	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.37e-05	0.00415	CbGpPWpGaD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.32e-05	0.00412	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	7.14e-05	0.00402	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.03e-05	0.00396	CbGpPWpGaD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.88e-05	0.00388	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—MTHFR—osteoporosis	6.86e-05	0.00386	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—TPI1—osteoporosis	6.85e-05	0.00386	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—WDR1—osteoporosis	6.78e-05	0.00382	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.74e-05	0.00379	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.71e-05	0.00378	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	6.57e-05	0.0037	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	6.51e-05	0.00367	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—P4HB—osteoporosis	6.44e-05	0.00363	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	6.42e-05	0.00362	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.4e-05	0.0036	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GAPDH—osteoporosis	6.32e-05	0.00356	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	6.19e-05	0.00348	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—RAP1A—osteoporosis	6.16e-05	0.00347	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—ADCY5—osteoporosis	6.14e-05	0.00346	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	5.9e-05	0.00332	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.89e-05	0.00332	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.58e-05	0.00314	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	5.45e-05	0.00307	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.4e-05	0.00304	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	5.37e-05	0.00302	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—ADCY5—osteoporosis	5.36e-05	0.00302	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CAP1—osteoporosis	5.36e-05	0.00302	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.32e-05	0.00299	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.25e-05	0.00295	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—ADCY5—osteoporosis	5.14e-05	0.00289	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.12e-05	0.00288	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	5e-05	0.00282	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ENO1—osteoporosis	4.98e-05	0.0028	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	4.93e-05	0.00278	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PSMA2—osteoporosis	4.91e-05	0.00276	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PSMA5—osteoporosis	4.91e-05	0.00276	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—ADCY5—osteoporosis	4.9e-05	0.00276	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	4.87e-05	0.00274	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	4.87e-05	0.00274	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—ADCY5—osteoporosis	4.7e-05	0.00265	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	4.69e-05	0.00264	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—IGF1—osteoporosis	4.52e-05	0.00255	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	4.43e-05	0.00249	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.36e-05	0.00245	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.31e-05	0.00243	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	4.31e-05	0.00243	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.3e-05	0.00242	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MGLL—osteoporosis	4.26e-05	0.0024	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—ADCY5—osteoporosis	4.11e-05	0.00231	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL1B—osteoporosis	4.07e-05	0.00229	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP19A1—osteoporosis	3.98e-05	0.00224	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.98e-05	0.00224	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ANXA2—osteoporosis	3.89e-05	0.00219	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PLEK—osteoporosis	3.89e-05	0.00219	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.88e-05	0.00218	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	3.63e-05	0.00204	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.57e-05	0.00201	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.37e-05	0.0019	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TLN1—osteoporosis	3.36e-05	0.00189	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VCL—osteoporosis	3.31e-05	0.00186	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ADCY5—osteoporosis	3.25e-05	0.00183	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GPX1—osteoporosis	3.24e-05	0.00182	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	3.23e-05	0.00182	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.19e-05	0.0018	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.1e-05	0.00175	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—MTHFR—osteoporosis	2.99e-05	0.00168	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—POMC—osteoporosis	2.96e-05	0.00167	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TNF—osteoporosis	2.95e-05	0.00166	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	2.93e-05	0.00165	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—FDPS—osteoporosis	2.8e-05	0.00157	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PKM—osteoporosis	2.8e-05	0.00157	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RAP1A—osteoporosis	2.77e-05	0.00156	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.76e-05	0.00156	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—TGFB1—osteoporosis	2.71e-05	0.00153	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PGLS—osteoporosis	2.65e-05	0.00149	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GPD2—osteoporosis	2.65e-05	0.00149	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.64e-05	0.00148	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.64e-05	0.00148	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	2.59e-05	0.00146	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.59e-05	0.00146	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.58e-05	0.00145	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.53e-05	0.00142	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—FGA—osteoporosis	2.51e-05	0.00141	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ATIC—osteoporosis	2.42e-05	0.00137	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PNP—osteoporosis	2.42e-05	0.00137	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PKM—osteoporosis	2.4e-05	0.00135	CbGpPWpGaD
Clonazepam—ALB—Metabolism—FDPS—osteoporosis	2.4e-05	0.00135	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—POMC—osteoporosis	2.39e-05	0.00135	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL6—osteoporosis	2.38e-05	0.00134	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.35e-05	0.00132	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.29e-05	0.00129	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—FGB—osteoporosis	2.28e-05	0.00129	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GPD2—osteoporosis	2.28e-05	0.00128	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PGLS—osteoporosis	2.28e-05	0.00128	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.26e-05	0.00127	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.21e-05	0.00124	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	2.09e-05	0.00118	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PNP—osteoporosis	2.08e-05	0.00117	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ATIC—osteoporosis	2.08e-05	0.00117	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—OXCT1—osteoporosis	2.06e-05	0.00116	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CA2—osteoporosis	2.06e-05	0.00116	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MGLL—osteoporosis	2.01e-05	0.00113	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.01e-05	0.00113	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.89e-05	0.00107	CbGpPWpGaD
Clonazepam—ALB—Metabolism—OXCT1—osteoporosis	1.77e-05	0.000998	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CA2—osteoporosis	1.77e-05	0.000998	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MGLL—osteoporosis	1.73e-05	0.000972	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—IDH2—osteoporosis	1.71e-05	0.000962	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.63e-05	0.000917	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP27A1—osteoporosis	1.61e-05	0.000904	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ACP5—osteoporosis	1.56e-05	0.00088	CbGpPWpGaD
Clonazepam—ALB—Metabolism—IDH2—osteoporosis	1.47e-05	0.000827	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TPI1—osteoporosis	1.45e-05	0.000818	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP27A1—osteoporosis	1.38e-05	0.000777	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—POMC—osteoporosis	1.38e-05	0.000774	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—P4HB—osteoporosis	1.37e-05	0.000769	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ACP5—osteoporosis	1.34e-05	0.000756	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GAPDH—osteoporosis	1.34e-05	0.000755	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.33e-05	0.000746	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—RAP1A—osteoporosis	1.31e-05	0.000735	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PKM—osteoporosis	1.3e-05	0.00073	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—FDPS—osteoporosis	1.3e-05	0.00073	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.26e-05	0.000712	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TPI1—osteoporosis	1.25e-05	0.000703	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PGLS—osteoporosis	1.23e-05	0.000692	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GPD2—osteoporosis	1.23e-05	0.000692	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.2e-05	0.000677	CbGpPWpGaD
Clonazepam—ALB—Metabolism—P4HB—osteoporosis	1.17e-05	0.000661	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GAPDH—osteoporosis	1.15e-05	0.000649	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ATIC—osteoporosis	1.12e-05	0.000633	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PNP—osteoporosis	1.12e-05	0.000633	CbGpPWpGaD
Clonazepam—ALB—Metabolism—RAP1A—osteoporosis	1.12e-05	0.000632	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ENO1—osteoporosis	1.06e-05	0.000594	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PSMA2—osteoporosis	1.04e-05	0.000585	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PSMA5—osteoporosis	1.04e-05	0.000585	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IGF1—osteoporosis	1.03e-05	0.000582	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.78e-06	0.000551	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—OXCT1—osteoporosis	9.56e-06	0.000539	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CA2—osteoporosis	9.56e-06	0.000539	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MGLL—osteoporosis	9.32e-06	0.000525	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ENO1—osteoporosis	9.07e-06	0.000511	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PSMA2—osteoporosis	8.94e-06	0.000503	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PSMA5—osteoporosis	8.94e-06	0.000503	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP19A1—osteoporosis	8.44e-06	0.000475	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—IDH2—osteoporosis	7.93e-06	0.000446	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.45e-06	0.00042	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP19A1—osteoporosis	7.25e-06	0.000408	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ACP5—osteoporosis	7.25e-06	0.000408	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ADCY5—osteoporosis	6.89e-06	0.000388	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GPX1—osteoporosis	6.87e-06	0.000387	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TPI1—osteoporosis	6.74e-06	0.000379	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—MTHFR—osteoporosis	6.34e-06	0.000357	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—P4HB—osteoporosis	6.34e-06	0.000357	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GAPDH—osteoporosis	6.22e-06	0.00035	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TGFB1—osteoporosis	6.2e-06	0.000349	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—RAP1A—osteoporosis	6.06e-06	0.000341	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ADCY5—osteoporosis	5.92e-06	0.000334	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GPX1—osteoporosis	5.9e-06	0.000332	CbGpPWpGaD
Clonazepam—ALB—Metabolism—MTHFR—osteoporosis	5.45e-06	0.000307	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—POMC—osteoporosis	5.07e-06	0.000285	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ENO1—osteoporosis	4.9e-06	0.000276	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PSMA2—osteoporosis	4.82e-06	0.000272	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PSMA5—osteoporosis	4.82e-06	0.000272	CbGpPWpGaD
Clonazepam—ALB—Metabolism—POMC—osteoporosis	4.36e-06	0.000245	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.91e-06	0.00022	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ADCY5—osteoporosis	3.2e-06	0.00018	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GPX1—osteoporosis	3.19e-06	0.000179	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—MTHFR—osteoporosis	2.94e-06	0.000166	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—POMC—osteoporosis	2.35e-06	0.000132	CbGpPWpGaD
